Galectin-3 regulates the expression of tumor glycosaminoglycans and increases the metastatic potential of breast cancer
Carregando...
Data
Data de publicação
Autores IPEN
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
Journal of Oncology
ODS
Exportar
Resumo
Galectin-3 (Gal-3) is a multifunctional β-galactoside-binding lectin that once synthesized is expressed in the nucleus, cytoplasm,
cell surface, and extracellular environment. Gal-3 plays an important role in breast cancer tumors due to its ability to promote
interactions between cell-cell and cell-extracellular matrix (ECM) elements, increasing tumor survival and metastatic dissemination.
Still, the mechanism by which Gal-3 interferes with tumor cell migration and metastasis formation is complex and not
fully understood. Here, we showed that Gal-3 knockdown increased the migration ability of 4T1 murine breast cancer cells in vitro.
Using the 4T1 orthotopic breast cancer spontaneous metastasis mouse model, we demonstrated that 4T1-derived tumors were
significantly larger in the presence of Gal-3 (scramble) in comparison with Gal-3 knockdown 4T1-derived tumors. Nevertheless,
Gal-3 knockdown 4T1 cells were outnumbered in the bone marrow in comparison with scramble 4T1 cells. Finally, we reported
here a decrease in the content of cell-surface syndecan-1 and an increase in the levels of chondroitin sulfate proteoglycans such as
versican in Gal-3 knockdown 4T1 cells both in vitro and in vivo. Overall, our findings establish that Gal-3 downregulation during
breast cancer progression regulates cell-associated and tumor microenvironment glycosaminoglycans (GAGs)/proteoglycans
(PG), thus enhancing the metastatic potential of tumor cells.
Como referenciar
PEREIRA, JONATHAS X.; SANTOS, SOFIA N. dos; PEREIRA, THAIS C.; CABANEL, MARIANA; CHAMMAS, ROGER; OLIVEIRA, FELIPE L. de; BERNARDES, EMERSON S.; EL-CHEIKH, MARCIA C. Galectin-3 regulates the expression of tumor glycosaminoglycans and increases the metastatic potential of breast cancer. Journal of Oncology, v. 2019, p. 1-15, 2019. DOI: 10.1155/2019/9827147. Disponível em: http://repositorio.ipen.br/handle/123456789/30836. Acesso em: 30 Dec 2025.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.